Biotech ETF (XBI) Outperforms, Up 3.75%
Tweet
Share
E-mailBiotech ETF (XBI) Outperforms, Up 3.75%
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly’s Retevmo approved by FDA for RET Tumors
- Eli Lilly (LLY) PT Raised to $1,385 at Bernstein SocGen Group
- Brussels prepares fresh Google fines as big tech enforcement increases - FT
Create E-mail Alert Related Categories
ETFs, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
